Dose escalation trial of docetaxel plus irinotecan in patients with advanced cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel; Irinotecan
- Indications Solid tumours
- Focus Adverse reactions
- 01 Sep 2009 Actual patient number (47) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2009 Actual end date (May 2006) added as reported by ClinicalTrials.gov.